X‑linked OGT dosage as a sex‑specific regulator of hexosamine biosynthetic pathway flux and proteostatic resilience

Hypothesis

If X-linked OGT dosage determines sex differences in longevity through hexosamine biosynthetic pathway (HBP) flux and O‑GlcNAc‑mediated proteostasis, then equalizing OGT expression between sexes will eliminate the female survival advantage under isoglycemic conditions.

Mechanistic Rationale

OGT is encoded on the X chromosome and escapes inactivation in a subset of tissues, potentially giving females higher O‑GlcNAc transferase activity【https://pmc.ncbi.nlm.nih.gov/articles/PMC3985334/】. Elevated O‑GlcNAcylation modifies key regulators of the heat‑shock response (HSF1) and autophagy (TFEB), enhancing chaperone expression and autophagic flux, which reduces protein aggregate burden【https://www.pnas.org/doi/10.1073/pnas.1205748109】. Concurrently, HBP flux rises with normal aging【https://doi.org/10.1101/2023.11.17.567640】 and drives pathological O‑GlcNAcylation when unbalanced, but a moderate increase supports proteostasis【https://www.ahajournals.org/doi/10.1161/JAHA.119.014046】. Because GFAT is the rate‑limiting step【https://pmc.ncbi.nlm.nih.gov/articles/PMC1343508/】, females may maintain a more favorable O‑GlcNAc cycling set‑point that buffers against aggregate‑induced toxicity.

Experimental Design

1. Model: Use C57BL/6J mice with a floxed Ogt allele and a Cre‑ERt2 system for inducible, tissue‑specific knockdown or overexpression.
2. Groups (n=30 per sex per group):
   • Females with Ogt knockdown to ~50 % (male‑like) expression.
   • Males with Ogt overexpression to ~150 % (female‑like) expression.
   • Sex‑matched controls receiving vehicle.
3. Conditions: Maintain all mice on a low‑glucose, isocaloric diet (5 % kcal from glucose) to control systemic glycemia; monitor fasting glucose weekly.
4. Readouts (at 12, 18, 24 months):
   • Survival curves.
   • Tissue‑specific O‑GlcNAc levels (Western blot with RL2 antibody).
   • HBP flux measured via UDP‑GlcNAc accumulation (LC‑MS).
   • Proteostasis markers: Hsp70, LC3‑II/I ratio, p62 levels; filter‑trap assay for ubiquitinated aggregates.
   • Behavioral frailty index.
5. Statistical analysis: Cox proportional hazards for survival; two‑way ANOVA for biochemical endpoints.

Predicted Outcomes

• Females with reduced Ogt will show shortened lifespan, elevated aggregate burden, and decreased autophagic flux, reaching male‑like values.
• Males with increased Ogt will exhibit extended median lifespan, lower O‑GlcNAc‑modified FoxO1 phosphorylation, enhanced TFEB nuclear localization, and reduced protein aggregates compared with controls.
• These effects will persist despite matched glucose levels, confirming that OGT dosage, not hyperglycemia, drives the sex difference.

Potential Caveats & Alternatives

• Compensatory upregulation of OGA (O‑GlcNAcase) could mask OGT changes; measure OGA activity.
• Tissue‑specific escape from X‑inactivation may limit systemic effects; validate Ogt expression in liver, brain, and muscle.
• If lifespan is unchanged, the hypothesis would be falsified, suggesting that other X‑linked genes or hormonal factors dominate longevity differences.

[End]